APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Probiotics CDMO Service

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Probiotics CDMO Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 17422153035 June 2026196 pages

Choose your research edition.

Industry ResearchProbiotics CDMO Service Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Probiotics CDMO Service Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Probiotics CDMO Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Probiotics CDMO Service Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Probiotics CDMO Service Market Analysis and Forecast 2026-2032187 pages · $4,950 USD

Market perspective

The global Probiotics CDMO Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Probiotics CDMO Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Probiotics CDMO Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Probiotics CDMO Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Probiotics CDMO Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Probiotics CDMO Service include Lallemand Health Solutions, Biofarma Group, ILDONG Bioscience Co., Ltd., Bioprox Healthcare, Huro Biotech, CKD BiO Corp, Biose Industrie, Rise Therapeutics and Chr. Hansen, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Probiotics CDMO Service market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Probiotics CDMO Service and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Probiotics CDMO Service revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Probiotics CDMO Service market size, projected growth trends, production technologies, key applications, and end-use industries.

Probiotics CDMO Service Segment by Company

Lallemand Health Solutions

Biofarma Group

ILDONG Bioscience Co., Ltd.

Bioprox Healthcare

Huro Biotech

CKD BiO Corp

Biose Industrie

Rise Therapeutics

Chr. Hansen

Lonza AG

Exden

JuneYao Group (BioGrowing)

Sacco System

Falorni srl

Inpac Probiotics

Glac Biotech Co., Ltd

Probiotics CDMO Service Segment by Type

Oral Dosage Forms (Capsules And Tablets)

Powders and Granules

Liquid Preparations

Probiotics CDMO Service Segment by Application

Medicines and Health Products

Food

Pet Food

Cosmetics

Probiotics CDMO Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Probiotics CDMO Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Probiotics CDMO Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Probiotics CDMO Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Probiotics CDMO Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Probiotics CDMO Service industry.

Chapter 3: Detailed analysis of Probiotics CDMO Service companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Probiotics CDMO Servicerevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Probiotics CDMO Service Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Oral Dosage Forms (Capsules And Tablets) Table 3. Key Players of Powders and Granules Table 4. Key Players of Liquid Preparations Table 4. Global Probiotics CDMO Service Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Medicines and Health Products Table 6. Key Players of Food Table 7. Key Players of Pet Food Table 8. Key Players of Cosmetics Table 9. Global Probiotics CDMO Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Probiotics CDMO Service Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Probiotics CDMO Service Market Share by Region (2021-2026) Table 12. Global Probiotics CDMO Service Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Probiotics CDMO Service Market Share by Region (2027-2032) Table 14. Probiotics CDMO Service Industry Trends Table 15. Probiotics CDMO Service Industry Drivers Table 16. Probiotics CDMO Service Industry Opportunities and Challenges Table 17. Probiotics CDMO Service Industry Restraints Table 18. Global Probiotics CDMO Service Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Probiotics CDMO Service Revenue Market Share by Company (2021-2026) Table 20. Global Probiotics CDMO Service Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Probiotics CDMO Service Key Company Head Office and Area Served Table 22. Global Probiotics CDMO Service Company, Product Type & Application Table 23. Global Probiotics CDMO Service Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Probiotics CDMO Service by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Probiotics CDMO Service Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Probiotics CDMO Service Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Probiotics CDMO Service Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Probiotics CDMO Service Revenue Market Share by Type (2021-2026) Table 30. Global Probiotics CDMO Service Revenue Market Share by Type (2027-2032) Table 31. Global Probiotics CDMO Service Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Probiotics CDMO Service Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Probiotics CDMO Service Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Probiotics CDMO Service Revenue Market Share by Application (2021-2026) Table 35. Global Probiotics CDMO Service Revenue Market Share by Application (2027-2032) Table 36. Lallemand Health Solutions Company Information Table 37. Lallemand Health Solutions Business Overview Table 38. Lallemand Health Solutions Probiotics CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Lallemand Health Solutions Probiotics CDMO Service Product Portfolio Table 40. Lallemand Health Solutions Recent Development Table 41. Biofarma Group Company Information Table 42. Biofarma Group Business Overview Table 43. Biofarma Group Probiotics CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Biofarma Group Probiotics CDMO Service Product Portfolio Table 45. Biofarma Group Recent Development Table 46. ILDONG Bioscience Co., Ltd. Company Information Table 47. ILDONG Bioscience Co., Ltd. Business Overview Table 48. ILDONG Bioscience Co., Ltd. Probiotics CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. ILDONG Bioscience Co., Ltd. Probiotics CDMO Service Product Portfolio Table 50. ILDONG Bioscience Co., Ltd. Recent Development Table 51. Bioprox Healthcare Company Information Table 52. Bioprox Healthcare Business Overview Table 53. Bioprox Healthcare Probiotics CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Bioprox Healthcare Probiotics CDMO Service Product Portfolio Table 55. Bioprox Healthcare Recent Development Table 56. Huro Biotech Company Information Table 57. Huro Biotech Business Overview Table 58. Huro Biotech Probiotics CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Huro Biotech Probiotics CDMO Service Product Portfolio Table 60. Huro Biotech Recent Development Table 61. CKD BiO Corp Company Information Table 62. CKD BiO Corp Business Overview Table 63. CKD BiO Corp Probiotics CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. CKD BiO Corp Probiotics CDMO Service Product Portfolio Table 65. CKD BiO Corp Recent Development Table 66. Biose Industrie Company Information Table 67. Biose Industrie Business Overview Table 68. Biose Industrie Probiotics CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Biose Industrie Probiotics CDMO Service Product Portfolio Table 70. Biose Industrie Recent Development Table 71. Rise Therapeutics Company Information Table 72. Rise Therapeutics Business Overview Table 73. Rise Therapeutics Probiotics CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Rise Therapeutics Probiotics CDMO Service Product Portfolio Table 75. Rise Therapeutics Recent Development Table 76. Chr. Hansen Company Information Table 77. Chr. Hansen Business Overview Table 78. Chr. Hansen Probiotics CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Chr. Hansen Probiotics CDMO Service Product Portfolio Table 80. Chr. Hansen Recent Development Table 81. Lonza AG Company Information Table 82. Lonza AG Business Overview Table 83. Lonza AG Probiotics CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Lonza AG Probiotics CDMO Service Product Portfolio Table 85. Lonza AG Recent Development Table 86. Exden Company Information Table 87. Exden Business Overview Table 88. Exden Probiotics CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 89. Exden Probiotics CDMO Service Product Portfolio Table 90. Exden Recent Development Table 91. JuneYao Group (BioGrowing) Company Information Table 92. JuneYao Group (BioGrowing) Business Overview Table 93. JuneYao Group (BioGrowing) Probiotics CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 94. JuneYao Group (BioGrowing) Probiotics CDMO Service Product Portfolio Table 95. JuneYao Group (BioGrowing) Recent Development Table 96. Sacco System Company Information Table 97. Sacco System Business Overview Table 98. Sacco System Probiotics CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 99. Sacco System Probiotics CDMO Service Product Portfolio Table 100. Sacco System Recent Development Table 101. Falorni srl Company Information Table 102. Falorni srl Business Overview Table 103. Falorni srl Probiotics CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 104. Falorni srl Probiotics CDMO Service Product Portfolio Table 105. Falorni srl Recent Development Table 106. Inpac Probiotics Company Information Table 107. Inpac Probiotics Business Overview Table 108. Inpac Probiotics Probiotics CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 109. Inpac Probiotics Probiotics CDMO Service Product Portfolio Table 110. Inpac Probiotics Recent Development Table 111. Glac Biotech Co., Ltd Company Information Table 112. Glac Biotech Co., Ltd Business Overview Table 113. Glac Biotech Co., Ltd Probiotics CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 114. Glac Biotech Co., Ltd Probiotics CDMO Service Product Portfolio Table 115. Glac Biotech Co., Ltd Recent Development Table 116. North America Probiotics CDMO Service Market Size by Type (2021-2026) & (US$ Million) Table 117. North America Probiotics CDMO Service Market Size by Type (2027-2032) & (US$ Million) Table 118. North America Probiotics CDMO Service Market Size by Application (2021-2026) & (US$ Million) Table 119. North America Probiotics CDMO Service Market Size by Application (2027-2032) & (US$ Million) Table 120. North America Probiotics CDMO Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 121. North America Probiotics CDMO Service Market Size by Country (2021-2026) Table 122. North America Probiotics CDMO Service Market Size by Country (2027-2032) Table 123. Europe Probiotics CDMO Service Market Size by Type (2021-2026) & (US$ Million) Table 124. Europe Probiotics CDMO Service Market Size by Type (2027-2032) & (US$ Million) Table 125. Europe Probiotics CDMO Service Market Size by Application (2021-2026) & (US$ Million) Table 126. Europe Probiotics CDMO Service Market Size by Application (2027-2032) & (US$ Million) Table 127. Europe Probiotics CDMO Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 128. Europe Probiotics CDMO Service Market Size by Country (2021-2026) Table 129. Europe Probiotics CDMO Service Market Size by Country (2027-2032) Table 130. China Probiotics CDMO Service Market Size by Type (2021-2026) & (US$ Million) Table 131. China Probiotics CDMO Service Market Size by Type (2027-2032) & (US$ Million) Table 132. China Probiotics CDMO Service Market Size by Application (2021-2026) & (US$ Million) Table 133. China Probiotics CDMO Service Market Size by Application (2027-2032) & (US$ Million) Table 134. Asia Probiotics CDMO Service Market Size by Type (2021-2026) & (US$ Million) Table 135. Asia Probiotics CDMO Service Market Size by Type (2027-2032) & (US$ Million) Table 136. Asia Probiotics CDMO Service Market Size by Application (2021-2026) & (US$ Million) Table 137. Asia Probiotics CDMO Service Market Size by Application (2027-2032) & (US$ Million) Table 138. Asia Probiotics CDMO Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 139. Asia Probiotics CDMO Service Market Size by Country (2021-2026) Table 140. Asia Probiotics CDMO Service Market Size by Country (2027-2032) Table 141. South America, Middle East & Africa Probiotics CDMO Service Market Size by Type (2021-2026) & (US$ Million) Table 142. South America, Middle East & Africa Probiotics CDMO Service Market Size by Type (2027-2032) & (US$ Million) Table 143. South America, Middle East & Africa Probiotics CDMO Service Market Size by Application (2021-2026) & (US$ Million) Table 144. South America, Middle East & Africa Probiotics CDMO Service Market Size by Application (2027-2032) & (US$ Million) Table 145. South America, Middle East & Africa Probiotics CDMO Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 146. South America, Middle East & Africa Probiotics CDMO Service Market Size by Country (2021-2026) Table 147. South America, Middle East & Africa Probiotics CDMO Service Market Size by Country (2027-2032) Table 148. Research Programs/Design for This Report Table 149. Authors List of This Report Table 150. Secondary Sources Table 151. Primary Sources List of Figures Figure 1. Probiotics CDMO Service Product Image Figure 2. Global Probiotics CDMO Service Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Probiotics CDMO Service Market Share by Type: 2025 VS 2032 Figure 4. Oral Dosage Forms (Capsules And Tablets) Image Figure 5. Powders and Granules Image Figure 6. Liquid Preparations Image Figure 7. Global Probiotics CDMO Service Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Probiotics CDMO Service Market Share by Application: 2025 VS 2032 Figure 9. Medicines and Health Products Image Figure 10. Food Image Figure 11. Pet Food Image Figure 12. Cosmetics Image Figure 13. Global Probiotics CDMO Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Probiotics CDMO Service Market Size (2021-2032) & (US$ Million) Figure 15. Global Probiotics CDMO Service Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Probiotics CDMO Service Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Probiotics CDMO Service Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Probiotics CDMO Service Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Probiotics CDMO Service Revenue Market Share by Type (2021-2032) Figure 22. Global Probiotics CDMO Service Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Probiotics CDMO Service Revenue Market Share by Application (2021-2032) Figure 24. North America Probiotics CDMO Service Market Size (2021-2032) & (US$ Million) Figure 25. North America Probiotics CDMO Service Market Share by Type (2021-2032) Figure 26. North America Probiotics CDMO Service Market Share by Application (2021-2032) Figure 27. North America Probiotics CDMO Service Market Share by Country (2021-2032) Figure 28. United States Probiotics CDMO Service Market Size (2021-2032) & (US$ Million) Figure 29. Canada Probiotics CDMO Service Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Probiotics CDMO Service Market Size (2021-2032) & (US$ Million) Figure 31. Europe Probiotics CDMO Service Market Size (2021-2032) & (US$ Million) Figure 32. Europe Probiotics CDMO Service Market Share by Type (2021-2032) Figure 33. Europe Probiotics CDMO Service Market Share by Application (2021-2032) Figure 34. Europe Probiotics CDMO Service Market Share by Country (2021-2032) Figure 35. Germany Probiotics CDMO Service Market Size (2021-2032) & (US$ Million) Figure 36. France Probiotics CDMO Service Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Probiotics CDMO Service Market Size (2021-2032) & (US$ Million) Figure 38. Italy Probiotics CDMO Service Market Size (2021-2032) & (US$ Million) Figure 39. Russia Probiotics CDMO Service Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Probiotics CDMO Service Market Size (2021-2032) & (US$ Million) Figure 41. China Probiotics CDMO Service Market Size (2021-2032) & (US$ Million) Figure 42. China Probiotics CDMO Service Market Share by Type (2021-2032) Figure 43. China Probiotics CDMO Service Market Share by Application (2021-2032) Figure 44. Asia Probiotics CDMO Service Market Size (2021-2032) & (US$ Million) Figure 45. Asia Probiotics CDMO Service Market Share by Type (2021-2032) Figure 46. Asia Probiotics CDMO Service Market Share by Application (2021-2032) Figure 47. Asia Probiotics CDMO Service Market Share by Country (2021-2032) Figure 48. Japan Probiotics CDMO Service Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Probiotics CDMO Service Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Probiotics CDMO Service Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Probiotics CDMO Service Market Size (2021-2032) & (US$ Million) Figure 52. India Probiotics CDMO Service Market Size (2021-2032) & (US$ Million) Figure 53. Australia Probiotics CDMO Service Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Probiotics CDMO Service Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Probiotics CDMO Service Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Probiotics CDMO Service Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Probiotics CDMO Service Market Share by Country (2021-2032) Figure 58. Brazil Probiotics CDMO Service Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Probiotics CDMO Service Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Probiotics CDMO Service Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Probiotics CDMO Service Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Probiotics CDMO Service Market Size (2021-2032) & (US$ Million) Figure 63. UAE Probiotics CDMO Service Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Probiotics CDMO Service Market Size (2021-2032) & (US$ Million) Figure 65. Chile Probiotics CDMO Service Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Oral Dosage Forms (Capsules And Tablets)
  • Powders and Granules
  • Liquid Preparations
Applications
  • Medicines and Health Products
  • Food
  • Pet Food
  • Cosmetics
Companies covered
  • Lallemand Health Solutions
  • Biofarma Group
  • ILDONG Bioscience Co., Ltd.
  • Bioprox Healthcare
  • Huro Biotech
  • CKD BiO Corp
  • Biose Industrie
  • Rise Therapeutics
  • Chr. Hansen
  • Lonza AG
  • Exden
  • JuneYao Group (BioGrowing)
  • Sacco System
  • Falorni srl
  • Inpac Probiotics
  • Glac Biotech Co., Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Probiotics CDMO Service Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Oral Dosage Forms (Capsules And Tablets)
  5. 1.2.3 Powders and Granules
  6. 1.2.4 Liquid Preparations
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Probiotics CDMO Service Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Medicines and Health Products
  10. 1.3.3 Food
  11. 1.3.4 Pet Food
  12. 1.3.5 Cosmetics
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Probiotics CDMO Service Growth Trends by Region
  15. 1.5.1 Global Probiotics CDMO Service Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Probiotics CDMO Service Market Size by Region (2021-2026)
  17. 1.5.3 Probiotics CDMO Service Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Probiotics CDMO Service Market Dynamics
  1. 2.1 Probiotics CDMO Service Industry Trends
  2. 2.2 Probiotics CDMO Service Industry Drivers
  3. 2.3 Probiotics CDMO Service Industry Opportunities and Challenges
  4. 2.4 Probiotics CDMO Service Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Probiotics CDMO Service Revenue by Company (2021-2026)
  2. 3.2 Global Probiotics CDMO Service Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Probiotics CDMO Service Key Company Head office and Area Served
  4. 3.4 Global Probiotics CDMO Service Company, Product Type & Application
  5. 3.5 Global Probiotics CDMO Service Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Probiotics CDMO Service Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Probiotics CDMO Service Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Probiotics CDMO Service Tier 1, Tier 2, and Tier 3
4 Probiotics CDMO Service Market by Type
  1. 4.1 Global Probiotics CDMO Service Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Probiotics CDMO Service Market Size by Type (2021-2032)
  3. 4.3 Global Probiotics CDMO Service Market Size Share by Type (2021-2032)
5 Probiotics CDMO Service Market by Application
  1. 5.1 Global Probiotics CDMO Service Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Probiotics CDMO Service Market Size by Application (2021-2032)
  3. 5.3 Global Probiotics CDMO Service Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Lallemand Health Solutions
  2. 6.1.1 Lallemand Health Solutions Company Information
  3. 6.1.2 Lallemand Health Solutions Business Overview
  4. 6.1.3 Lallemand Health Solutions Probiotics CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Lallemand Health Solutions Probiotics CDMO Service Product Portfolio
  6. 6.1.5 Lallemand Health Solutions Recent Developments
  7. 6.2 Biofarma Group
  8. 6.2.1 Biofarma Group Company Information
  9. 6.2.2 Biofarma Group Business Overview
  10. 6.2.3 Biofarma Group Probiotics CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Biofarma Group Probiotics CDMO Service Product Portfolio
  12. 6.2.5 Biofarma Group Recent Developments
  13. 6.3 ILDONG Bioscience Co., Ltd.
  14. 6.3.1 ILDONG Bioscience Co., Ltd. Company Information
  15. 6.3.2 ILDONG Bioscience Co., Ltd. Business Overview
  16. 6.3.3 ILDONG Bioscience Co., Ltd. Probiotics CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 ILDONG Bioscience Co., Ltd. Probiotics CDMO Service Product Portfolio
  18. 6.3.5 ILDONG Bioscience Co., Ltd. Recent Developments
  19. 6.4 Bioprox Healthcare
  20. 6.4.1 Bioprox Healthcare Company Information
  21. 6.4.2 Bioprox Healthcare Business Overview
  22. 6.4.3 Bioprox Healthcare Probiotics CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Bioprox Healthcare Probiotics CDMO Service Product Portfolio
  24. 6.4.5 Bioprox Healthcare Recent Developments
  25. 6.5 Huro Biotech
  26. 6.5.1 Huro Biotech Company Information
  27. 6.5.2 Huro Biotech Business Overview
  28. 6.5.3 Huro Biotech Probiotics CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Huro Biotech Probiotics CDMO Service Product Portfolio
  30. 6.5.5 Huro Biotech Recent Developments
  31. 6.6 CKD BiO Corp
  32. 6.6.1 CKD BiO Corp Company Information
  33. 6.6.2 CKD BiO Corp Business Overview
  34. 6.6.3 CKD BiO Corp Probiotics CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 CKD BiO Corp Probiotics CDMO Service Product Portfolio
  36. 6.6.5 CKD BiO Corp Recent Developments
  37. 6.7 Biose Industrie
  38. 6.7.1 Biose Industrie Company Information
  39. 6.7.2 Biose Industrie Business Overview
  40. 6.7.3 Biose Industrie Probiotics CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Biose Industrie Probiotics CDMO Service Product Portfolio
  42. 6.7.5 Biose Industrie Recent Developments
  43. 6.8 Rise Therapeutics
  44. 6.8.1 Rise Therapeutics Company Information
  45. 6.8.2 Rise Therapeutics Business Overview
  46. 6.8.3 Rise Therapeutics Probiotics CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Rise Therapeutics Probiotics CDMO Service Product Portfolio
  48. 6.8.5 Rise Therapeutics Recent Developments
  49. 6.9 Chr. Hansen
  50. 6.9.1 Chr. Hansen Company Information
  51. 6.9.2 Chr. Hansen Business Overview
  52. 6.9.3 Chr. Hansen Probiotics CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Chr. Hansen Probiotics CDMO Service Product Portfolio
  54. 6.9.5 Chr. Hansen Recent Developments
  55. 6.10 Lonza AG
  56. 6.10.1 Lonza AG Company Information
  57. 6.10.2 Lonza AG Business Overview
  58. 6.10.3 Lonza AG Probiotics CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Lonza AG Probiotics CDMO Service Product Portfolio
  60. 6.10.5 Lonza AG Recent Developments
  61. 6.11 Exden
  62. 6.11.1 Exden Company Information
  63. 6.11.2 Exden Business Overview
  64. 6.11.3 Exden Probiotics CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Exden Probiotics CDMO Service Product Portfolio
  66. 6.11.5 Exden Recent Developments
  67. 6.12 JuneYao Group (BioGrowing)
  68. 6.12.1 JuneYao Group (BioGrowing) Company Information
  69. 6.12.2 JuneYao Group (BioGrowing) Business Overview
  70. 6.12.3 JuneYao Group (BioGrowing) Probiotics CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 JuneYao Group (BioGrowing) Probiotics CDMO Service Product Portfolio
  72. 6.12.5 JuneYao Group (BioGrowing) Recent Developments
  73. 6.13 Sacco System
  74. 6.13.1 Sacco System Company Information
  75. 6.13.2 Sacco System Business Overview
  76. 6.13.3 Sacco System Probiotics CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Sacco System Probiotics CDMO Service Product Portfolio
  78. 6.13.5 Sacco System Recent Developments
  79. 6.14 Falorni srl
  80. 6.14.1 Falorni srl Company Information
  81. 6.14.2 Falorni srl Business Overview
  82. 6.14.3 Falorni srl Probiotics CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Falorni srl Probiotics CDMO Service Product Portfolio
  84. 6.14.5 Falorni srl Recent Developments
  85. 6.15 Inpac Probiotics
  86. 6.15.1 Inpac Probiotics Company Information
  87. 6.15.2 Inpac Probiotics Business Overview
  88. 6.15.3 Inpac Probiotics Probiotics CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Inpac Probiotics Probiotics CDMO Service Product Portfolio
  90. 6.15.5 Inpac Probiotics Recent Developments
  91. 6.16 Glac Biotech Co., Ltd
  92. 6.16.1 Glac Biotech Co., Ltd Company Information
  93. 6.16.2 Glac Biotech Co., Ltd Business Overview
  94. 6.16.3 Glac Biotech Co., Ltd Probiotics CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Glac Biotech Co., Ltd Probiotics CDMO Service Product Portfolio
  96. 6.16.5 Glac Biotech Co., Ltd Recent Developments
7 North America
  1. 7.1 North America Probiotics CDMO Service Market Size (2021-2032)
  2. 7.2 North America Probiotics CDMO Service Market Size by Type
  3. 7.2.1 North America Probiotics CDMO Service Market Size by Type (2021-2026)
  4. 7.2.2 North America Probiotics CDMO Service Market Size by Type (2027-2032)
  5. 7.2.3 North America Probiotics CDMO Service Market Share by Type (2021-2032)
  6. 7.3 North America Probiotics CDMO Service Market Size by Application
  7. 7.3.1 North America Probiotics CDMO Service Market Size by Application (2021-2026)
  8. 7.3.2 North America Probiotics CDMO Service Market Size by Application (2027-2032)
  9. 7.3.3 North America Probiotics CDMO Service Market Share by Application (2021-2032)
  10. 7.4 North America Probiotics CDMO Service Market Size by Country
  11. 7.4.1 North America Probiotics CDMO Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Probiotics CDMO Service Market Size by Country (2021-2026)
  13. 7.4.3 North America Probiotics CDMO Service Market Size by Country (2027-2032)
  14. 7.4.4 North America Probiotics CDMO Service Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Probiotics CDMO Service Market Size (2021-2032)
  2. 8.2 Europe Probiotics CDMO Service Market Size by Type
  3. 8.2.1 Europe Probiotics CDMO Service Market Size by Type (2021-2026)
  4. 8.2.2 Europe Probiotics CDMO Service Market Size by Type (2027-2032)
  5. 8.2.3 Europe Probiotics CDMO Service Market Share by Type (2021-2032)
  6. 8.3 Europe Probiotics CDMO Service Market Size by Application
  7. 8.3.1 Europe Probiotics CDMO Service Market Size by Application (2021-2026)
  8. 8.3.2 Europe Probiotics CDMO Service Market Size by Application (2027-2032)
  9. 8.3.3 Europe Probiotics CDMO Service Market Share by Application (2021-2032)
  10. 8.4 Europe Probiotics CDMO Service Market Size by Country
  11. 8.4.1 Europe Probiotics CDMO Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Probiotics CDMO Service Market Size by Country (2021-2026)
  13. 8.4.3 Europe Probiotics CDMO Service Market Size by Country (2027-2032)
  14. 8.4.4 Europe Probiotics CDMO Service Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Probiotics CDMO Service Market Size (2021-2032)
  2. 9.2 China Probiotics CDMO Service Market Size by Type
  3. 9.2.1 China Probiotics CDMO Service Market Size by Type (2021-2026)
  4. 9.2.2 China Probiotics CDMO Service Market Size by Type (2027-2032)
  5. 9.2.3 China Probiotics CDMO Service Market Share by Type (2021-2032)
  6. 9.3 China Probiotics CDMO Service Market Size by Application
  7. 9.3.1 China Probiotics CDMO Service Market Size by Application (2021-2026)
  8. 9.3.2 China Probiotics CDMO Service Market Size by Application (2027-2032)
  9. 9.3.3 China Probiotics CDMO Service Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Probiotics CDMO Service Market Size (2021-2032)
  2. 10.2 Asia Probiotics CDMO Service Market Size by Type
  3. 10.2.1 Asia Probiotics CDMO Service Market Size by Type (2021-2026)
  4. 10.2.2 Asia Probiotics CDMO Service Market Size by Type (2027-2032)
  5. 10.2.3 Asia Probiotics CDMO Service Market Share by Type (2021-2032)
  6. 10.3 Asia Probiotics CDMO Service Market Size by Application
  7. 10.3.1 Asia Probiotics CDMO Service Market Size by Application (2021-2026)
  8. 10.3.2 Asia Probiotics CDMO Service Market Size by Application (2027-2032)
  9. 10.3.3 Asia Probiotics CDMO Service Market Share by Application (2021-2032)
  10. 10.4 Asia Probiotics CDMO Service Market Size by Country
  11. 10.4.1 Asia Probiotics CDMO Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Probiotics CDMO Service Market Size by Country (2021-2026)
  13. 10.4.3 Asia Probiotics CDMO Service Market Size by Country (2027-2032)
  14. 10.4.4 Asia Probiotics CDMO Service Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Probiotics CDMO Service Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Probiotics CDMO Service Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Probiotics CDMO Service Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Probiotics CDMO Service Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Probiotics CDMO Service Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Probiotics CDMO Service Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Probiotics CDMO Service Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Probiotics CDMO Service Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Probiotics CDMO Service Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Probiotics CDMO Service Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Probiotics CDMO Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Probiotics CDMO Service Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Probiotics CDMO Service Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Probiotics CDMO Service Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst